Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

JINZHEN for Treatment of Mild to Moderate COVID-19

ClinicalTrials.gov ID: NCT05092503

Public ClinicalTrials.gov record NCT05092503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/Ⅱ Randomized Controlled Proof-of-concept Study to Evaluate the Safety and Efficacy of JINZHEN Granules for Oral Solution in Participants With Mild to Moderate COVID-19

Study identification

NCT ID
NCT05092503
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Lianyungang Kanion Group, Ltd.
Industry
Enrollment
60 participants

Conditions and interventions

Conditions

Interventions

  • JINZHEN Granules for Oral Solution Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2022
Primary completion
May 11, 2023
Completion
May 11, 2023
Last update posted
Mar 19, 2024

2022 – 2023

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Clearview Medical Research LLC Canyon Country California 91351
Family First Medical Research Center Hialeah Gardens Florida 33016
LMG Research Miami Florida 33016
AA Medical Research Center Flint Michigan 48504
F. Gabriel LLC Bayonne New Jersey 07002
Carolina Institute for Clinical Research Fayetteville North Carolina 28303
Frontier Clinical Research LLC Smithfield Pennsylvania 15478
Piedmont Research Partners Fort Mill South Carolina 29707
SMS Clinical Research Mesquite Texas 75149
Frontier Clinical Research LLC Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05092503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 19, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05092503 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →